Industry & Business

DPS wins contract for €100 million clinical manufacturing facility in the US

 Breaking News
  • Arkphire Secures New Investment IT solutions and networking company, Arkphire, has announced that Bregal Milestone, a private capital firm, has completed an investment into the business. The investment by Bregal Milestone comes from their new €400 million pan-European fund dedicated to investing in high-growth European companies. Typical commitments from Bregal Milestone range from €20 million to €60 million. Arkphire provides [...]...
  • Government Investment in Research & Development Amounts to Over €750 Million in 2018 The latest figures on Government investment in research and development (R&D), published by the Department of Business, Enterprise and Innovation, show that over €750 million is estimated to have been invested in R&D in 2018. The data in The Research and Development Budget 2017-2018 publication is compiled from a comprehensive survey of thirty Government Departments [...]...
  • Smart Dublin in Partnership With Enterprise Ireland Award 21 New Innovation Contracts Approximately €700,000 is to be awarded to companies under Enterprise Ireland’s Small Business Innovation Research (SBIR) initiative which will enable them explore innovative solutions to address challenges faced by Local Authorities. 21 companies have been awarded Phase One funding to progress the feasibility of their solutions. Phase One funding will allow each recipient to carry [...]...
  • Tourism Industry Barometer Reflects Buoyant Year But Hints at Brexit Concerns Tourism performance throughout 2018 continues to be on a strong footing, according to the latest Fáilte Ireland Tourism Barometer. The survey of more than 500 tourism businesses around the country shows over half of the tourism industry is reporting their business to be up, with two thirds (64%) saying that tourism agency supports have been [...]...
  • Glanbia to Acquire SlimFast For $350 Million Glanbia, the global nutrition group, has agreed to acquire SlimFast and other brands for $350 million from the owners KSF Holdings LLP and HNS Intermediate Corporation. SlimFast is a leading weight management and health & wellness brand family distributed primarily in the food, drug, mass and club (FDMC) channel in the US and UK. It [...]...

DPS wins contract for €100 million clinical manufacturing facility in the US

DPS wins contract for €100 million clinical manufacturing facility in the US
October 11
14:30 2016

Engineering group DPS, alongside its US architectural partner TRIA, has won a major contract to work on Moderna Therapeutics’ new €100 million clinical manufacturing facility in Norwood, Massachusetts.

DPS is providing full architectural and engineering design, as well as project management services, for the 200,000 sq. ft. facility. The finished site will provide Good Manufacturing Practice (GMP) standards for the clinical manufacture of mRNA therapies.

The investment in the facility is a huge one for the clinical stage biotechnology company. Moderna Therapeutics will carry out all manufacturing activities at the site, from raw material production to active pharmaceutical ingredients, formulation, filling and finish.

The full range of services that DPS and TRIA are set to offer will ensure that the Norwood facility can manufacture, control and supply clinical grade mRNA therapies, which Moderna hope can create a new generation of transformative medicines.

DPS CEO Frank Keogh says: “This is a significant contract win for DPS and builds on the strong relationship we have developed with Moderna. We are proud to be supporting Moderna with this major investment in Norwood. This project demonstrates DPS’s ability to bid for and win large-scale capital investment design projects in the US.”

If Moderna’s therapies receive regulatory approval, the Norwood site will become the manufacturing base for these therapies to be supplied to patients worldwide.

Commenting on the project, senior vice president of manufacturing and operations at Moderna, Steve Harbin, said: “This is quite an ambitious project and will result in a truly unique facility… This will be among the most integrated end-to-end process facilities I have built and seen in my 25 years working in the pharmaceutical industry.”

Construction of the site is due to begin this month, with an estimated completion date of early 2018.

About Author

admin

admin

Related Articles

New Subscriber





Subscribe Here



Advertisements



















National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories



Upcoming Events

  • No upcoming events
AEC v1.0.4